Hydrogen Water Study Tests Benefits for Parkinson's Disease Symptoms
Randomized, double‐blind, multicenter trial of hydrogen water for Parkinson's disease
Research hubs: Parkinson's Disease · Brain & Nervous System
- Evidence type
- Randomized controlled trial · Human study
- Authors
- Asako Yoritaka, Chigumi Ohtsuka, Tetsuya Maeda, Masaaki Hirayama, Takashi Abe, Hirohisa Watanabe, Hidemoto Saiki, Genko Oyama, Jiro Fukae, Yasushi Shimo, Taku Hatano, Sumihiro Kawajiri, Yasuyuki Okuma, Yutaka Machida, Hideto Miwa, Chikako Suzuki, Asuka Kazama, Masahiko Tomiyama, Takeshi Kihara, Motoyuki Hirasawa, Hideki Shimura, Eisei Oda, Mikako Ito, Kinji Ohno, Nobutaka Hattori
- Journal
- Movement Disorders
- Year
- 2018
- DOI
- 10.1002/mds.27472
- Study Type
- Human
- Outcome
- Neutral
- Peer Reviewed
- Yes
- Country
- Japan
- Health Condition
- Parkinson's Disease
- Body System
- Nervous System
TL;DR
This study is testing if drinking hydrogen-rich water can help improve symptoms in Parkinson's disease patients over a 72-week period.
Key Finding
This is a trial protocol describing a planned study; results are not yet available, so no findings can be reported at this time.
Summary
This study is testing whether drinking hydrogen water (water with dissolved hydrogen gas) can help improve symptoms in people with Parkinson's disease. Researchers are comparing 178 Parkinson's patients who drink 1000 mL of hydrogen water daily to those who drink regular water, measuring changes in their motor symptoms and quality of life over 72 weeks using a standard rating scale.
Practical Takeaway
This is an ongoing clinical trial, not a completed study with results. While a previous smaller study suggested hydrogen water might help Parkinson's symptoms, this larger multicenter trial is still underway to confirm those findings. Anyone interested in hydrogen water for Parkinson's should wait for the final results before drawing conclusions.
Abstract (excerpt)
Background: Our previous randomized double-blind study showed that drinking hydrogen (H2) water for 48 weeks significantly improved the total Unified Parkinson’s Disease Rating Scale (UPDRS) score of Parkinson’s disease (PD) patients treated with levodopa. We aim to confirm this result using…